Jiongjiong Lu
- Cancer Research top 10%
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 7
- Hepatology top 10%
-
- Circular RNAs in diseases 5
- RNA modifications and cancer 3
- Metabolomics and Mass Spectrometry Studies 1
-
- Liver Disease Diagnosis and Treatment 2
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
-
- Cancer Mechanisms and Therapy 1
- Partner nations
- China
In The Last Decade
Jiongjiong Lu
20 papers receiving 493 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 301
- Hepatology 102
- Molecular Biology 334
- Epidemiology 87
- Pulmonary and Respiratory Medicine 64
Countries citing papers authored by Jiongjiong Lu
This map shows the geographic impact of Jiongjiong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiongjiong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiongjiong Lu more than expected).
Fields of papers citing papers by Jiongjiong Lu
This network shows the impact of papers produced by Jiongjiong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiongjiong Lu. The network helps show where Jiongjiong Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiongjiong Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 6 | |
| 5 | 2022 | 36 | |
| 6 | 2022 | 10 | |
| 7 | 2022 | 11 | |
| 8 | 2021 | 6 | |
| 9 | 2020 | 43 | |
| 10 | 2019 | 34 | |
| 11 | 2019 | 38 | |
| 12 | 2017 | 18 | |
| 13 | 2016 | 85 | |
| 14 | 2016 | 16 | |
| 15 | MicroRNA-147 suppresses human hepatocellular carcinoma proliferation migration and chemosensitivity by inhibiting HOXC6. | 2016 | 29 |
| 16 | 2015 | 41 | |
| 17 | 2015 | 18 | |
| 18 | 2014 | 17 | |
| 19 | 2014 | 57 | |
| 20 | 2013 | 25 |
About Jiongjiong Lu
Jiongjiong Lu is a scholar working on Cancer Research, Hepatology and Molecular Biology, having authored 20 papers that have together received 498 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (5 papers), RNA modifications and cancer (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Metabolomics and Mass Spectrometry Studies (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Cancer Research (301 citations), Hepatology (102 citations) and Molecular Biology (334 citations). Jiongjiong Lu has collaborated with scholars based in China. Frequent co-authors include Chengjun Sui, Weifeng Shen, Binghua Dai, Jiamei Yang, Geng Li, Jiamei Yang, Feng Xie, Yanming Zhou, Minfeng Zhang and Feng Xie. Their work appears in journals such as Tumor Biology, BMC Gastroenterology, Oncology Reports, Frontiers in Immunology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.